Stockholm3 for prostate cancer screening (MIB303)
NICE has developed a medtech innovation briefing (MIB) on Stockholm3 for prostate cancer screening
Search results
7 results for template
-
-
Vaccine uptake in the general population (NG218)
This guideline aims to increase the uptake of all vaccines provided on the NHS routine UK immunisation schedule by everyone who is eligible. It supports the aims of the NHS Long Term Plan , which includes actions to improve immunisation coverage by GPs (including the changes to vaccinations and immunisations detailed in the 2021/2022 and 2022/23 GP contracts ) and support a narrowing of health inequalities.
-
Mental wellbeing at work (NG212)
This guideline covers how to create the right conditions for mental wellbeing at work. It aims to promote a supportive and inclusive work environment, including training and support for managers and helping people who have or are at risk of poor mental health.
-
What is the most clinically and cost-effective pathway for diagnosing clinically significant prostate cancer?
evidence, the committee recommended not offering mapping transperineal template biopsy as an initial biopsy, because the technique is...
-
Prostate cancer: diagnosis and management (NG131)
This guideline covers the diagnosis and management of prostate cancer in secondary care, including information on the best way to diagnose and identify different stages of the disease, and how to manage adverse effects of treatment. It also includes recommendations on follow-up in primary care for people diagnosed with prostate cancer.
-
ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infections (MTG62)
Evidence-based recommendations on ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infections
-
Paige Prostate for prostate cancer (MIB280)
NICE has developed a medtech innovation briefing (MIB) on Paige Prostate for prostate cancer